The CytoSinct™ CD8 Nanobeads (human) are used for separating CD8+ cells from fresh or frozen peripheral blood mononuclear cells (PBMCs), leukapheresis products or single cell suspension based on the surface expression of human CD8. The surface of Nanobeads are labeled with anti-human CD8 monoclonal antibody. To begin the isolation, Nanobeads are added to the cells. The CD8 antibodies preconjugated to the Nanobeads can bind the target cells expressing CD8 on cell surface. The cells/beads mixed suspension is loaded onto a CytoSinct™ Column which is effectively magnetized by an external magnetic field from CytoSinct™ Magnet, or other compatible cell isolation columns and magnets. The NanoBeads-labeled CD8+ cells are retained within the column and enriched during the wash step when Isolation Buffer is used to flush out the CD8- cells. After removing magnetic field, the target CD8+ cells can be easily eluted from the column.
Specification
Components: Nanobeads conjugated to monoclonal mouse anti-human CD8 antibodies (isotype: mouse IgG1) under optimal conditions. Volume: 7.5 mL, Up to 4X10^10 total MNCs Reactivity: Human Formulation: Supplied in buffer containing stabilizer Storage: Nanobeads conjugated to monoclonal mouse anti-human CD8 antibodies (isotype: mouse IgG1) under optimal conditions.
Features
Gmp Grade Ultra Purity High Recovery High Viability Nano-sized Bio-degradable Bio-compatible Cost Efficient